Skip to main content
. 2022 May 17;42(6):1230–1243. doi: 10.1007/s10875-022-01278-6

Fig. 1.

Fig. 1

Overall and event-free survival. A. Overall survival (OS) was 97% and event-free survival (EFS) was 51% at 20 years post-transplant for our cohort (n = 83). B. Impact on EFS of age at transplant. EFS at 20 years post-transplant was 61% in patients less than 1 year, 51% in those aged 1 to 4 years, and 41% in those 5 years or older at transplant